Generics in Russia - Market Summary, Competitive Analysis and Forecast to 2025
Generics in Russia - Market @Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Generics in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Russian generics market had total revenues of $9.3bn in 2020, representing a compound annual growth rate (CAGR) of 11.3% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 5.8% between 2016 and 2020, to reach a total of 76.0% in 2020.
- The Russian market is the third largest in the European region, accounting for 11.9% of its total value in 2020. A key driver of growth in the Russian market is that the country has a large smoking population.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Russia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Russia
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Russia generics market with five year forecasts
- What was the size of the Russia generics market by value in 2020?
- What will be the size of the Russia generics market in 2025?
- What factors are affecting the strength of competition in the Russia generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Russia's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Krka, d. d., Novo mesto
8.2. Teva Pharmaceutical Industries Limited
8.3. Abbott Laboratories
8.4. Sanofi SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Krka, d. d., Novo mesto
8.2. Teva Pharmaceutical Industries Limited
8.3. Abbott Laboratories
8.4. Sanofi SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Russia generics market value: $ billion, 2016-20
Table 2: Russia generics market volume: %, 2016-20
Table 3: Russia generics market geography segmentation: $ billion, 2020
Table 4: Russia generics market value forecast: $ billion, 2020-25
Table 5: Russia generics market volume forecast: %, 2020-25
Table 6: Krka, d. d., Novo mesto: key facts
Table 7: Krka, d. d., Novo mesto: Annual Financial Ratios
Table 8: Krka, d. d., Novo mesto: Key Employees
Table 9: Krka, d. d., Novo mesto: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Abbott Laboratories: key facts
Table 14: Abbott Laboratories: Annual Financial Ratios
Table 15: Abbott Laboratories: Key Employees
Table 16: Abbott Laboratories: Key Employees Continued
Table 17: Sanofi SA: key facts
Table 18: Sanofi SA: Annual Financial Ratios
Table 19: Sanofi SA: Key Employees
Table 20: Sanofi SA: Key Employees Continued
Table 21: Russia size of population (million), 2016-20
Table 22: Russia gdp (constant 2005 prices, $ billion), 2016-20
Table 23: Russia gdp (current prices, $ billion), 2016-20
Table 24: Russia inflation, 2016-20
Table 25: Russia consumer price index (absolute), 2016-20
Table 26: Russia exchange rate, 2016-20
Table 1: Russia generics market value: $ billion, 2016-20
Table 2: Russia generics market volume: %, 2016-20
Table 3: Russia generics market geography segmentation: $ billion, 2020
Table 4: Russia generics market value forecast: $ billion, 2020-25
Table 5: Russia generics market volume forecast: %, 2020-25
Table 6: Krka, d. d., Novo mesto: key facts
Table 7: Krka, d. d., Novo mesto: Annual Financial Ratios
Table 8: Krka, d. d., Novo mesto: Key Employees
Table 9: Krka, d. d., Novo mesto: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Abbott Laboratories: key facts
Table 14: Abbott Laboratories: Annual Financial Ratios
Table 15: Abbott Laboratories: Key Employees
Table 16: Abbott Laboratories: Key Employees Continued
Table 17: Sanofi SA: key facts
Table 18: Sanofi SA: Annual Financial Ratios
Table 19: Sanofi SA: Key Employees
Table 20: Sanofi SA: Key Employees Continued
Table 21: Russia size of population (million), 2016-20
Table 22: Russia gdp (constant 2005 prices, $ billion), 2016-20
Table 23: Russia gdp (current prices, $ billion), 2016-20
Table 24: Russia inflation, 2016-20
Table 25: Russia consumer price index (absolute), 2016-20
Table 26: Russia exchange rate, 2016-20
LIST OF FIGURES
Figure 1: Russia generics market value: $ billion, 2016-20
Figure 2: Russia generics market volume: %, 2016-20
Figure 3: Russia generics market geography segmentation: % share, by value, 2020
Figure 4: Russia generics market value forecast: $ billion, 2020-25
Figure 5: Russia generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Russia, 2020
Figure 7: Drivers of buyer power in the generics market in Russia, 2020
Figure 8: Drivers of supplier power in the generics market in Russia, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Russia, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Russia, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Russia, 2020
Figure 1: Russia generics market value: $ billion, 2016-20
Figure 2: Russia generics market volume: %, 2016-20
Figure 3: Russia generics market geography segmentation: % share, by value, 2020
Figure 4: Russia generics market value forecast: $ billion, 2020-25
Figure 5: Russia generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Russia, 2020
Figure 7: Drivers of buyer power in the generics market in Russia, 2020
Figure 8: Drivers of supplier power in the generics market in Russia, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Russia, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Russia, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Russia, 2020
